Genetic and Rare Diseases Information Center (GARD)


Granuloma annulare
Please note that the links contained on this search results page may take you to sites outside of the NIH. (See Disclaimer under Site Policies for details.)


For more information about Granuloma annulare click on the boxes below:
Q&A More
Information
Support
Groups
Research &
Clinical Trials
More Search
Tools

Do you have information granuloma annulare? I have been diagnosed with this condition and the treatments I've tried have not worked so far.



  • What is granuloma annulare? (Back to Top)

  • Granuloma annulare is a long-term (chronic) skin disease consisting of a rash with reddish bumps arranged in a circle or ring.[1]
  • Last Reviewed: 9/23/2008
  • What symptoms are associated with granuloma annulare? (Back to Top)

  • People with this condition usually notice a ring of small, firm bumps (papules) over the backs of the forearms, hands or feet. Occasionally, multiple rings may be found. Rarely, granuloma annulare may appear as a firm nodule under the skin of the arms or legs.[1]
  • Last Reviewed: 9/23/2008
  • What causes granuloma annulare? (Back to Top)

  • The cause of granuloma annulare is unknown, although there is much evidence that it is linked to the immune system.[1][2] It has been reported to follow insect bites; sun exposure; tuberculin skin tests, ingestion of allopurinol; trauma; and viral infections, including Epstein-Barr, HIV, hepatitis C, and herpes zoster. Occasionally, granuloma annulare may be associated with diabetes or thyroid disease.[1]
  • Last Reviewed: 9/23/2008
  • How might granuloma annulare be treated? (Back to Top)

  • Granuloma annulare is difficult to treat and there are a limited number of clinical trials to reliably inform patients and physicians of the treatment options. Fortunately, most lesions of granuloma annulare disappear with no treatment within two years. Sometimes, however, the rings can remain for many years.[4] Very strong topical steroid creams or ointments may be used to speed the disappearance of the lesions. Injections of steroids directly into the rings may also be effective. Some physicians may choose to freeze the lesions with liquid nitrogen. In severe cases, ultraviolet light therapy (PUVA) or oral medications may be needed.[1]

    Other treatments that have been tried include [4][3]:

    • Dapsone (a type of antibiotic) for widespread granuloma annulare 
    • Etretinate (not available in the US) 
    • Chloroquine 
    • Cyclosporine 
    • Niacinamide 
    • Oral psoralen 
    • Vitamin E combined with a 5-lipoxygenase inhibitor 
    • Fumaric acid esters 
    • Topical tacrolimus 
    • Pimecrolimus 
    • Infliximab (in a patient with disseminated granuloma annulare that did not respond to other treatments)

    A review article titled, 'Diagnosis and Management of Granuloma Annulare' provides additional information on treatment options for granuloma annulare: http://www.aafp.org/afp/20061115/1729.html 

    Also, an article from eMedicine Journal provides information on treatment for granuloma annulare at the following link. You may need to register to view the article, but registration is free.
    http://www.emedicine.com/derm/topic169.htm


  • Last Reviewed: 9/23/2008
  • Are there any clinical trials investigating new treatments for granuloma annulare? (Back to Top)

  • Yes. The U.S. National Institutes of Health, through the National Library of Medicine, developed ClinicalTrials.gov to provide patients, family members, and members of the public with current information on clinical research studies. Currently, 1 clinical trial is enrolling individuals with granuloma annulare, 'Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix.' Review the study's eligibility criteria to determine its appropriateness. Use the study’s contact information to learn more.

    In addition, there is a study, entitled 'Evaluation and Treatment of Patients Who Have Skin Diseases' which may be of interest to you. Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures, and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients' diagnosis, response to treatment, and/or disease progression. To view information about this clinical trial, click on the link above and review its eligibility criteria to determine its appropriateness.

    You can also contact the Patient Recruitment and Public Liaison Office at the National Institutes of Health (NIH). We recommend calling the toll-free number listed below to speak with a specialist, who can help you determine if there are any other trials which would be appropriate for an individual with granuloma annulare.

    Patient Recruitment and Public Liaison Office
    NIH Clinical Center
    Bethesda, Maryland 20892-2655
    Toll-free: 800-411-1222
    Fax: 301-480-9793
    Email: prpl@mail.cc.nih.gov
    Web site: "http://clinicalcenter.nih.gov/


  • Last Reviewed: 9/23/2008


References  (Back)
  1. Lehrer M. Granuloma Annulare. Medline Plus Web site. July 11, 2008 Available at: http://www.nlm.nih.gov/medlineplus/ency/article/000833.htm. Accessed September 23, 2008.
  2. Sabuncuoðlu H, Oge K, Söylemezoðlu F, Saðlam A. Subcutaneous granuloma annulare of the scalp in childhood: a case report and review of the literature [abstract]. Turk Neurosurg. 2007; 17(1):19-22. Accessed May 27, 2008. PMID:17918673.
  3. Freedberg, Irwin, et. al.. Fitzpatrick's Dermatology in General Medicine, 6th edition. United States: The McGraw-Hill Companies, Inc.; 2003.
  4. PR Cyr. Diagnosis and Management of Granuloma Annulare. American Family Physician. 2006; 74 (10): 1729-1734.




Note: If you need help accessing information in different file formats such as PDF, MP3, see Viewers, Players, and Plug-ins.